LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 103 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.08 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $824,000 | -95.5% | 67,055 | -93.9% | 0.05% | -95.7% |
| Q2 2017 | $18,187,000 | -25.0% | 1,105,610 | -34.6% | 1.24% | -6.6% |
| Q1 2017 | $24,239,000 | +15.5% | 1,690,273 | +11.4% | 1.33% | +31.1% |
| Q4 2016 | $20,988,000 | +43.4% | 1,517,575 | +87.4% | 1.02% | +51.3% |
| Q3 2016 | $14,631,000 | +106.2% | 809,666 | +63.8% | 0.67% | +72.1% |
| Q2 2016 | $7,094,000 | +13.2% | 494,380 | -5.7% | 0.39% | +13.4% |
| Q1 2016 | $6,266,000 | -39.2% | 524,380 | -32.3% | 0.34% | -31.3% |
| Q4 2015 | $10,307,000 | +3.7% | 774,380 | -16.3% | 0.50% | +4.6% |
| Q3 2015 | $9,935,000 | – | 925,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |